Eli Lilly & Co. is ramping up the fight against cheaper, copycat versions of Zepbound by lowering prices for a version of its blockbuster obesity drug.
The company is reducing the cost of its 2.… [read more]
Lilly Cuts Price of Zepbound to Battle Cheaper Copycats – Bloomberg
Date:
More like thisRelated
China Urges Shein to Halt Supply-Chain Shift After Tariffs – Bloomberg.com
Supply Lines is a daily newsletter that tracks global...
Yuan Devaluation Market Chatter Gets Louder as Trade War Worsens – Bloomberg.com
The deepening trade war is raising speculation in financial...
Chinese Stocks Rebound From Historic Rout as State Funds Step In – Bloomberg.com
Chinas stock market rebounded after a steep selloff on...